We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.06%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$819M
AUM Growth
+$126M
(+18%)
Cap. Flow
+$81.6M
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
58.25%
Holding
35
New
13
Increased
10
Reduced
8
Closed
3
Avg Time Held
4.8
quarters
Top 10 Avg Time Held
2.9
quarters
Top 20 Avg Time Held
5.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivaNova
LIVN
|
+$33.6M |
| 2 |
UnitedHealth
UNH
|
+$29.9M |
| 3 |
TSMC
TSM
|
+$22.5M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$22.4M |
| 5 |
Chemours
CC
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$31M |
| 2 |
Valvoline
VVV
|
+$22.5M |
| 3 |
Mercury Systems
MRCY
|
+$20.7M |
| 4 |
Dollar Tree
DLTR
|
+$20.6M |
| 5 |
AerCap
AER
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.54% |
| 2 | Consumer Discretionary | 25.34% |
| 3 | Healthcare | 14.17% |
| 4 | Materials | 12.43% |
| 5 | Technology | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Corteva
CTVA
$8.94B
| $63.4M | 7.74% |
850,285
-107,599
| -11% | -$7.17M |
2024 Q1
5 quarters
|
|
2
Regal Rexnord
RRX
$10.7B
| $58.6M | 7.16% |
404,469
+1,121
| +0.3% | +$141K |
2021 Q1
17 quarters
|
|
3
KBR
KBR
$4.48B
| $56.1M | 6.85% |
1,169,184
+216,832
| +23% | +$11.2M |
2020 Q2
20 quarters
|
|
4
SharkNinja
SN
$26.4B
| $55.2M | 6.74% |
557,683
+52,817
| +10% | +$4.57M |
2024 Q1
5 quarters
|
|
5
Somnigroup International
SGI
$14.3B
| $49.9M | 6.1% |
733,935
-39,557
| -5% | -$2.49M |
2022 Q3
11 quarters
|
|
6
Amazon
AMZN
$2.78T
| $48.4M | 5.92% |
220,805
+53,849
| +32% | +$10.7M |
2024 Q4
2 quarters
|
|
|
7
Chemours
CC
$1.95B
| $38.4M | 4.69% |
3,355,261
+1,401,539
| +72% | +$15.8M |
2024 Q3
3 quarters
|
|
|
8
LivaNova
LIVN
$4.21B
| $36.7M | 4.48% |
+814,243
| New | +$33.6M |
2025 Q2
0 quarters
|
|
|
9
AerCap
AER
$22.9B
| $36.3M | 4.44% |
310,481
-104,879
| -25% | -$11.3M |
2023 Q2
8 quarters
|
|
10
JB Hunt Transport Services
JBHT
$21.5B
| $33.8M | 4.13% |
235,325
+16,019
| +7% | +$2.22M |
2024 Q3
3 quarters
|
|
11
Primo Brands
PRMB
$6.82B
| $32.9M | 4.02% |
1,111,148
+191,489
| +21% | +$6.12M |
2025 Q1
1 quarter
|
|
12
Peloton Interactive
PTON
$2.25B
| $30.2M | 3.69% |
4,358,181
+697,865
| +19% | +$4.53M |
2022 Q1
13 quarters
|
|
13
Harmonic Inc
HLIT
$1.12B
| $28.7M | 3.51% |
3,031,755
-400,533
| -12% | -$3.65M |
2019 Q1
25 quarters
|
|
|
14
TSMC
TSM
$2.28T
| $27.5M | 3.36% |
+121,535
| New | +$22.5M |
2025 Q2
0 quarters
|
|
|
15
UnitedHealth
UNH
$348B
| $24.4M | 2.98% |
+78,314
| New | +$29.9M |
2025 Q2
0 quarters
|
|
16
Indivior Pharmaceuticals
INDV
$4.17B
| $24.4M | 2.98% |
1,654,855
-220,253
| -12% | -$2.57M |
2023 Q2
8 quarters
|
|
|
17
Mercury Systems
MRCY
$4.66B
| $24.1M | 2.94% |
446,623
-425,149
| -49% | -$20.7M |
2024 Q1
5 quarters
|
|
|
18
Bio-Rad Laboratories Class A
BIO
$9.75B
| $22.9M | 2.79% |
+94,737
| New | +$22.4M |
2025 Q2
0 quarters
|
|
19
EnerSys
ENS
$6.3B
| $20.5M | 2.5% |
238,652
-47,080
| -16% | -$4.1M |
2021 Q3
15 quarters
|
|
|
20
Valvoline
VVV
$3.84B
| $19.5M | 2.39% |
516,090
-643,051
| -55% | -$22.5M |
2025 Q1
1 quarter
|
|
21
Vestis
VSTS
$1.88B
| $16.6M | 2.03% |
2,896,583
+401,223
| +16% | +$2.82M |
2023 Q4
6 quarters
|
|
22
Entegris
ENTG
$24.1B
| $13.1M | 1.6% |
+162,179
| New | +$12.3M |
2025 Q2
0 quarters
|
|
23
Magnera Corp
MAGN
$390M
| $12.2M | 1.49% |
1,010,794
+321,579
| +47% | +$4.42M |
2024 Q4
2 quarters
|
|
24
DELISTED
Air Lease Corp
AL
| $12.2M | 1.49% |
+208,433
| New | +$10.8M |
2025 Q2
0 quarters
|
|
25
MongoDB
MDB
$29.5B
| $12M | 1.46% |
+57,006
| New | +$10.5M |
2025 Q2
0 quarters
|
|
Similar funds
TFS
WAM
CS
BU
TBFA
VDC
RQS
IMT
Scopia Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Scopia Capital Management held 35 positions worth $819M, up 18% from $692M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Scopia Capital Management deployed $81.6M of net new capital in Q2 2025, opening 13 new positions and adding to 10 existing holdings. Its largest new stake was LivaNova: 814,243 shares worth $36.7M.
By sector, the portfolio is most concentrated in Industrials at 32% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Valvoline, an estimated $22.5M trimmed.
- Scopia Capital Management's largest Q2 2025 buy was LivaNova: 814,243 shares worth $36.7M.
- Scopia Capital Management added most to Chemours in Q2 2025, an estimated $15.8M increase.
- Scopia Capital Management's biggest Q2 2025 reduction was Valvoline, cutting an estimated $22.5M.
- Scopia Capital Management fully exited DraftKings in Q2 2025, selling an estimated $31M.
- Scopia Capital Management's ten largest holdings make up 58% of its $819M portfolio in Q2 2025.
- Scopia Capital Management opened 13 new positions and closed 3 in Q2 2025.
- Scopia Capital Management's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Scopia Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.